Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07348666 · ClinicalTrials.gov registry record · NA
A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
A NA study, sponsored by Ksana Health.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07348666: Clinical Trial NA study, sponsored by Ksana Health.
NCT07348666 is a NA study that has not yet begun recruiting, run by Ksana Health. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07348666, a NA study, has not yet begun recruiting, sponsored by Ksana Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death amongst youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to increase engagement with effective interventions such as suicide safety planning. The BRITE suicide safety planning app was developed on evidence-based principles and has undergone rigorous formative development and effectiveness evaluations. However, to optimize its functionality, commercial viability, and scale its implementation, issues related to user engagement needed to be addressed. This 3 month Pragmatic Randomized Trial will evaluate the impact of the ViraSafe app-an enhanced version of the BRITE suicide safety planning app-on improving engagement with coping skills and safety planning among suicidal adolescents by comparing its intervention components to those of the original BRITE app.
Primary Outcome
Engagement with the ViraSafe app (i.e., tapping on the push notification, patterns of accessing app features such as coping skills and safety plan) and BRITE app (daily dose rating, post rating after accessing coping skill, editing coping skill content)
Interventions
- BEHAVIORAL ViraSafe: Treatment pushes
- BEHAVIORAL BRITE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-02-16 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What is known before NCT07348666 opens enrollment
NCT07348666 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which ViraSafe: Treatment pushes is the first listed.
NCT07348666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07348666 about?
NCT07348666 is a clinical study titled "A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents". Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death amongst youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to increase engagement with effective interventions such as suicide...
What is the current status of trial NCT07348666?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-02-16. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07348666?
The interventions under investigation include: ViraSafe: Treatment pushes (BEHAVIORAL), BRITE (BEHAVIORAL).
Who is sponsoring clinical trial NCT07348666?
This trial is sponsored by Ksana Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07348666's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI